Cargando…
In Vitro Pharmacodynamics and Bactericidal Mechanism of Fungal Defensin-Derived Peptides NZX and P2 against Streptococcus agalactiae
(1) Background: Based on the hazard of Streptococcus agalactiae to human and animal health and the increasing drug resistance, it is urgent to develop new antimicrobial agents with high bactericidal activity and low drug resistance against S. agalactiae. This study aims to investigate in vitro pharm...
Autores principales: | Wu, Yankang, Yang, Na, Mao, Ruoyu, Hao, Ya, Teng, Da, Wang, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142981/ https://www.ncbi.nlm.nih.gov/pubmed/35630326 http://dx.doi.org/10.3390/microorganisms10050881 |
Ejemplares similares
-
Pharmacokinetics and Pharmacodynamics of Fungal Defensin NZX Against Staphylococcus aureus-Induced Mouse Peritonitis Model
por: Zheng, Xueling, et al.
Publicado: (2022) -
Design and Pharmacodynamics of Recombinant Fungus Defensin NZL with Improved Activity against Staphylococcus hyicus In Vitro and In Vivo
por: Liu, He, et al.
Publicado: (2021) -
The Pharmacodynamics Study of Insect Defensin DLP4 Against Toxigenic Staphylococcus hyicus ACCC 61734 in Vitro and Vivo
por: Ma, Xuanxuan, et al.
Publicado: (2021) -
Molecular Modification of Kex2 P1’ Site Enhances Expression and Druggability of Fungal Defensin
por: Jin, Yanjie, et al.
Publicado: (2023) -
Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles
por: Tenland, Erik, et al.
Publicado: (2019)